deltatrials
Completed PHASE4 INTERVENTIONAL 4-arm NCT04969250

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

SARS-CoV-2 Vaccination Strategies in Previously Hospitalized and Recovered COVID-19 Patients

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Conditions Covid19
Updated 15 times since 2021 Last updated: Mar 26, 2024 Started: Aug 25, 2021 Primary completion: Dec 21, 2022 Completion: Dec 21, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04969250, this PHASE4 trial focuses on Covid19 and remains completed. Sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, it has been updated 15 times since 2021, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Jul 2022 · 4 months · monthly snapshot~Jul 2022 – ~Feb 2023 · 7 months · monthly snapshot~Feb 2023 – ~Jun 2023 · 4 months · monthly snapshot~Jun 2023 – ~Apr 2024 · 10 months · monthly snapshot~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

15 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jun 2024 — Jul 2024 [monthly]

    Completed PHASE4

  5. Apr 2024 — Jun 2024 [monthly]

    Completed PHASE4

Show 10 earlier versions
  1. Jun 2023 — Apr 2024 [monthly]

    Completed PHASE4

  2. Feb 2023 — Jun 2023 [monthly]

    Completed PHASE4

    Status: Active Not RecruitingCompleted

  3. Jul 2022 — Feb 2023 [monthly]

    Active Not Recruiting PHASE4

  4. Mar 2022 — Jul 2022 [monthly]

    Active Not Recruiting PHASE4

    Status: RecruitingActive Not Recruiting

  5. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE4

  6. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE4

  7. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE4

  8. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE4

  9. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE4

  10. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

    First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
  • Cardiothoracic Surgical Trials Network
  • International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
  • Kirby Institute
  • Medical Research Council
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Prevention and Early Treatment of Acute Lung Injury
  • US Department of Veterans Affairs
  • University of Copenhagen
  • University of Minnesota
  • Washington D.C. Veterans Affairs Medical Center
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .